All In MedTech

FDA Clearance Tracker · K080956

MODIFICATION TO VF GEL PLUS

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 21, 2026Latest source record: Apr 25, 2008 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K080956
Device name
MODIFICATION TO VF GEL PLUS
Applicant location
Palo Alto, CA
Received
Apr 3, 2008
Decided
Apr 25, 2008
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 874.3620

Every decision under product code MIX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MIX. The earliest in FDA's data is K972317, decided Sep 18, 1997.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K080956
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Coapt Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.